+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
From
From
Interstitial Cystitis Drugs Market 2024-2028 - Product Thumbnail Image

Interstitial Cystitis Drugs Market 2024-2028

  • Report
  • May 2024
  • 170 Pages
  • Global
From
Prostate Cancer Therapeutics Market - Product Thumbnail Image

Prostate Cancer Therapeutics Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Atopic Dermatitis (Atopic Eczema) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • March 2024
  • 1168 Pages
  • Global
From
From
From
Diabetic Neuropathic Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
Immunology Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Immunology Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 450 Pages
  • Global
From
From
Nivolumab Global Market Report 2024 - Product Thumbnail Image

Nivolumab Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Loading Indicator